XML 19 R2.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Balance Sheets - USD ($)
Mar. 31, 2022
Mar. 31, 2021
CURRENT ASSETS    
Cash $ 12,066,929 $ 2,201,562
Accounts receivable, net 2,006,678 1,520,836
Inventory 842,924 272,493
Deposits and other receivables 406,280 326,664
Total current assets 15,322,811 4,321,555
Deposits [Note 12] 85,000
Long-term accounts receivable 50,358
Property and equipment [Note 13] 27,459
Operating right of use asset [Note 12] 1,242,700 66,120
TOTAL ASSETS 16,677,970 4,438,033
CURRENT LIABILITIES    
Accounts payable and accrued liabilities [Note 4] 2,595,747 2,520,124
Convertible promissory notes and short term loans [Note 5] 1,540,000 4,278,018
Derivative liabilities [Note 8] 520,747 3,633,856
Operating lease obligations, current [Note 12] 210,320 58,257
Total current liabilities 4,866,814 10,490,255
Federally guaranteed loans [Note 7] 870,800 370,900
Term loan [Note 6] 11,612,672
Derivative liabilities [Note 8] 352,402 410,042
Operating lease obligations [Note 12] 1,120,018
TOTAL LIABILITIES 18,822,706 11,271,197
STOCKHOLDERS’ DEFICIENCY    
Preferred stock, value 1 1
Common stock, $0.001 par value, 125,000,000 authorized as at March 31, 2022 and March 31, 2021, respectively. Issued and outstanding common shares: 49,810,322 and 36,124,964 as at March 31, 2022 and March 31, 2021, respectively, and exchangeable shares of 1,466,718 and 2,889,978 outstanding as at March 31, 2022 and March 31, 2021, respectively [Note 9] 51,277 39,015
Shares to be issued (123,817 and 268,402 shares of common stock as at March 31, 2022 and March 31, 2021, respectively) [Note 9] 102,299 280,960
Additional paid-in-capital 91,507,478 56,298,726
Accumulated other comprehensive loss (768,656) (634,186)
Accumulated deficit (93,037,142) (62,817,688)
TOTAL STOCKHOLDERS’ DEFICIENCY (2,144,736) (6,833,164)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIENCY 16,677,970 4,438,033
Series A Preferred Stock [Member]    
STOCKHOLDERS’ DEFICIENCY    
Preferred stock, value $ 7 $ 8